PETS logo

PetMed Express (PETS) EBITDA

Annual EBITDA

-$1.11 M
-$10.70 M-111.52%

March 31, 2024

Summary

Performance

1-Year Change

-111.52%

3-Year Change

-103.36%

5-Year Change

-102.29%

15-Year Change

-102.85%

PETS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.8%
PETS annual EBITDA is higher than 77.8% of companies in Healthcare sector

High & Low

All-time High

$54.26 M
PETS annual EBITDA is currently -102.04% below its historical high of $54.26 million

3-Year Low

-$1.11 M
PETS annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
PETS previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
PETS next annual earnings announcement has not yet been scheduled

OtherPETSprofitabilitymetrics:

Annual Revenue

$281.06 M
PETS annual revenue is $281.06 million

Annual Net Income

-$7.46 M
PETS annual net profit is -$7.46 million

Annual EBIT

-$8.16 M
PETS annual earnings before interest & taxes is -$8.16 million

Annual EPS

-$0.37
PETS annual earnings per share is -$0.37

Quarterly EBITDA

$2.21 M
-$3.90 M-63.78%

September 30, 2024

Summary

Performance

3-Month Change

-63.78%

1-Year Change

+73.9%

3-Year Change

-65.02%

5-Year Change

-65.02%

PETS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.46%
PETS quarterly EBITDA is higher than 77.46% of companies in Healthcare sector

High & Low

All-time High

$16.31 M
PETS quarterly EBITDA is currently -86.44% below its historical high of $16.31 million

3-Year Low

-$1.94 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PETS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
PETS next earnings announcement is scheduled for Feb 10, 2025

OtherPETSprofitabilitymetrics:

Quarterly Revenue

$59.57 M
PETS quarterly revenue is $59.57 million

Quarterly Net Income

$2.33 M
PETS quarterly net profit is $2.33 million

Quarterly EBIT

$554.00 K
PETS quarterly earnings before interest & taxes is $554.00 thousand

Quarterly EPS

$0.11
PETS quarterly earnings per share is $0.11

TTM EBITDA

$5.08 M
+$940.00 K+22.73%

September 30, 2024

Summary

Performance

3-Month Change

+22.73%

1-Year Change

+185.75%

3-Year Change

-81.22%

5-Year Change

-81.22%

PETS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.22%
PETS TTM EBITDA is higher than 78.22% of companies in Healthcare sector

High & Low

All-time High

$56.61 M
PETS TTM EBITDA is currently -91.03% below its historical high of $56.61 million

3-Year Low

-$2.42 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PETS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
PETS next earnings announcement is scheduled for Feb 10, 2025

OtherPETSprofitabilitymetrics:

TTM Revenue

$259.34 M
PETS TTM revenue is $259.34 million

TTM Net Income

-$963.00 K
PETS TTM net profit is -$963.00 thousand

TTM EBIT

-$1.97 M
PETS TTM earnings before interest & taxes is -$1.97 million

TTM EPS

-$0.06
PETS TTM earnings per share is -$0.06

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$1.11 M
PETS annual EBITDA is -$1.11 million

Annual Net Income

-$7.46 M
PETS annual net profit is -$7.46 million

Annual Interest Expense

-
PETS annual interest expense value is unknown

Annual Income Tax

$1.19 M
PETS annual income tax is $1.19 million

Annual D&A

$7.06 M
PETS annual depreciation & amortization is $7.06 million

PETS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-111.5%+73.9%+185.8%
3 y3 years-103.4%-65.0%-81.2%
5 y5 years-102.3%-65.0%-81.2%

PETS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.4%at low-65.0%+214.0%-81.2%+309.5%
5 y5-year-102.3%at low-80.0%+214.0%-87.3%+309.5%
alltimeall time-102.0%+51.2%-86.4%+214.0%-91.0%+309.5%

PetMed Express EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.21 M(-63.8%)
$5.08 M(+22.7%)
Jun 2024
-
$6.11 M(-414.8%)
$4.13 M(-270.7%)
Mar 2024
-$1.11 M(-111.5%)
-$1.94 M(+48.8%)
-$2.42 M(-907.3%)
Dec 2023
-
-$1.30 M(-202.5%)
$300.00 K(-83.1%)
Sep 2023
-
$1.27 M(-382.7%)
$1.78 M(-58.9%)
Jun 2023
-
-$450.00 K(-157.5%)
$4.32 M(-51.1%)
Mar 2023
$9.60 M(-64.5%)
$782.00 K(+354.7%)
$8.84 M(-38.5%)
Dec 2022
-
$172.00 K(-95.5%)
$14.38 M(-28.3%)
Sep 2022
-
$3.82 M(-6.0%)
$20.06 M(-19.8%)
Jun 2022
-
$4.06 M(-35.7%)
$25.03 M(-7.4%)
Mar 2022
$27.03 M(-18.0%)
$6.32 M(+8.0%)
$27.03 M(+19.2%)
Dec 2021
-
$5.86 M(-33.3%)
$22.67 M(-15.2%)
Sep 2021
-
$8.78 M(+44.8%)
$26.73 M(-7.9%)
Jun 2021
-
$6.07 M(+208.4%)
$29.03 M(-11.9%)
Mar 2021
$32.96 M(-0.8%)
$1.97 M(-80.2%)
$32.96 M(-17.7%)
Dec 2020
-
$9.91 M(-10.5%)
$40.06 M(+3.7%)
Sep 2020
-
$11.08 M(+10.8%)
$38.64 M(+5.8%)
Jun 2020
-
$10.00 M(+10.3%)
$36.50 M(+9.8%)
Mar 2020
$33.23 M(-31.3%)
$9.07 M(+6.8%)
$33.23 M(+2.2%)
Dec 2019
-
$8.49 M(-5.0%)
$32.53 M(-4.3%)
Sep 2019
-
$8.94 M(+32.9%)
$34.00 M(-12.4%)
Jun 2019
-
$6.73 M(-19.5%)
$38.81 M(-19.8%)
Mar 2019
$48.40 M(-10.8%)
$8.36 M(-16.1%)
$48.40 M(-11.3%)
Dec 2018
-
$9.97 M(-27.5%)
$54.58 M(-3.6%)
Sep 2018
-
$13.76 M(-15.7%)
$56.61 M(+1.8%)
Jun 2018
-
$16.31 M(+12.2%)
$55.63 M(+2.5%)
Mar 2018
$54.26 M(+39.7%)
$14.54 M(+21.2%)
$54.26 M(+4.5%)
Dec 2017
-
$12.00 M(-6.1%)
$51.93 M(+8.1%)
Sep 2017
-
$12.78 M(-14.5%)
$48.05 M(+11.2%)
Jun 2017
-
$14.95 M(+22.4%)
$43.20 M(+11.2%)
Mar 2017
$38.85 M(+17.2%)
$12.21 M(+50.5%)
$38.85 M(+9.6%)
Dec 2016
-
$8.11 M(+2.2%)
$35.45 M(+0.9%)
Sep 2016
-
$7.93 M(-25.1%)
$35.13 M(+1.9%)
Jun 2016
-
$10.59 M(+20.2%)
$34.47 M(+4.0%)
Mar 2016
$33.16 M(+10.6%)
$8.81 M(+13.1%)
$33.16 M(+2.5%)
Dec 2015
-
$7.79 M(+7.1%)
$32.34 M(-0.1%)
Sep 2015
-
$7.28 M(-21.6%)
$32.38 M(+3.6%)
Jun 2015
-
$9.28 M(+16.1%)
$31.27 M(+4.3%)
Mar 2015
$29.99 M(+3.1%)
$7.99 M(+2.1%)
$29.99 M(+2.3%)
Dec 2014
-
$7.83 M(+27.1%)
$29.31 M(+2.0%)
Sep 2014
-
$6.16 M(-23.0%)
$28.74 M(-2.0%)
Jun 2014
-
$8.00 M(+9.4%)
$29.34 M(+0.9%)
Mar 2014
$29.09 M(+3.5%)
$7.31 M(+0.6%)
$29.08 M(-0.7%)
Dec 2013
-
$7.27 M(+7.5%)
$29.30 M(-0.7%)
Sep 2013
-
$6.76 M(-12.7%)
$29.50 M(+0.6%)
Jun 2013
-
$7.75 M(+2.9%)
$29.31 M(+4.3%)
Mar 2013
$28.10 M
$7.53 M(+0.8%)
$28.10 M(+3.3%)
Dec 2012
-
$7.46 M(+13.5%)
$27.21 M(+3.8%)
Sep 2012
-
$6.58 M(+0.7%)
$26.21 M(+0.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
$6.53 M(-1.6%)
$26.06 M(-5.0%)
Mar 2012
$27.43 M(-20.3%)
$6.64 M(+2.8%)
$27.43 M(-0.6%)
Dec 2011
-
$6.46 M(+0.5%)
$27.59 M(-3.2%)
Sep 2011
-
$6.43 M(-18.7%)
$28.51 M(-5.4%)
Jun 2011
-
$7.91 M(+16.4%)
$30.13 M(-12.4%)
Mar 2011
$34.40 M(-17.8%)
$6.79 M(-8.0%)
$34.40 M(-8.7%)
Dec 2010
-
$7.38 M(-8.2%)
$37.67 M(-3.4%)
Sep 2010
-
$8.04 M(-34.0%)
$39.01 M(-5.1%)
Jun 2010
-
$12.18 M(+21.0%)
$41.12 M(-1.8%)
Mar 2010
$41.86 M(+19.6%)
$10.07 M(+15.4%)
$41.86 M(+2.3%)
Dec 2009
-
$8.72 M(-14.1%)
$40.91 M(+3.3%)
Sep 2009
-
$10.15 M(-21.4%)
$39.59 M(+4.1%)
Jun 2009
-
$12.92 M(+41.7%)
$38.02 M(+8.6%)
Mar 2009
$35.02 M(+22.5%)
$9.12 M(+23.2%)
$35.02 M(+5.5%)
Dec 2008
-
$7.40 M(-13.8%)
$33.19 M(+2.9%)
Sep 2008
-
$8.58 M(-13.5%)
$32.25 M(+7.8%)
Jun 2008
-
$9.92 M(+36.0%)
$29.91 M(+4.6%)
Mar 2008
$28.59 M(+29.8%)
$7.29 M(+12.8%)
$28.59 M(+5.7%)
Dec 2007
-
$6.46 M(+3.6%)
$27.05 M(+10.0%)
Sep 2007
-
$6.24 M(-27.4%)
$24.59 M(+5.6%)
Jun 2007
-
$8.60 M(+49.3%)
$23.28 M(+5.7%)
Mar 2007
$22.03 M(+17.9%)
$5.76 M(+44.1%)
$22.03 M(+2.9%)
Dec 2006
-
$3.99 M(-19.0%)
$21.42 M(-0.1%)
Sep 2006
-
$4.93 M(-32.9%)
$21.45 M(+3.9%)
Jun 2006
-
$7.35 M(+42.9%)
$20.64 M(+10.4%)
Mar 2006
$18.69 M(+42.9%)
$5.14 M(+27.7%)
$18.69 M(+7.1%)
Dec 2005
-
$4.03 M(-2.2%)
$17.45 M(+4.5%)
Sep 2005
-
$4.12 M(-23.7%)
$16.70 M(+7.1%)
Jun 2005
-
$5.40 M(+38.4%)
$15.59 M(+19.2%)
Mar 2005
$13.08 M(+33.9%)
$3.90 M(+19.1%)
$13.08 M(+13.8%)
Dec 2004
-
$3.28 M(+8.8%)
$11.49 M(+11.3%)
Sep 2004
-
$3.01 M(+4.4%)
$10.32 M(-0.5%)
Jun 2004
-
$2.89 M(+24.8%)
$10.37 M(+6.3%)
Mar 2004
$9.76 M(+153.5%)
$2.31 M(+9.4%)
$9.76 M(+11.7%)
Dec 2003
-
$2.11 M(-30.9%)
$8.74 M(+17.8%)
Sep 2003
-
$3.06 M(+34.6%)
$7.42 M(+56.1%)
Jun 2003
-
$2.27 M(+75.8%)
$4.75 M(+23.4%)
Mar 2003
$3.85 M(+242.4%)
$1.29 M(+63.5%)
$3.85 M(-0.6%)
Dec 2002
-
$791.20 K(+100.9%)
$3.87 M(+9.9%)
Sep 2002
-
$393.90 K(-71.3%)
$3.53 M(+7.6%)
Jun 2002
-
$1.37 M(+4.1%)
$3.28 M(+191.5%)
Mar 2002
$1.12 M(-149.7%)
$1.32 M(+196.8%)
$1.12 M(-229.5%)
Dec 2001
-
$443.80 K(+204.0%)
-$868.20 K(-47.2%)
Sep 2001
-
$146.00 K(-118.7%)
-$1.64 M(-20.3%)
Jun 2001
-
-$782.40 K(+15.8%)
-$2.06 M(-8.9%)
Mar 2001
-$2.27 M(+29.0%)
-$675.60 K(+103.4%)
-$2.27 M(+42.5%)
Dec 2000
-
-$332.20 K(+21.6%)
-$1.59 M(+26.4%)
Sep 2000
-
-$273.30 K(-72.2%)
-$1.26 M(+27.8%)
Jun 2000
-
-$984.20 K
-$984.20 K
Mar 2000
-$1.76 M
-
-

FAQ

  • What is PetMed Express annual EBITDA?
  • What is the all time high annual EBITDA for PetMed Express?
  • What is PetMed Express annual EBITDA year-on-year change?
  • What is PetMed Express quarterly EBITDA?
  • What is the all time high quarterly EBITDA for PetMed Express?
  • What is PetMed Express quarterly EBITDA year-on-year change?
  • What is PetMed Express TTM EBITDA?
  • What is the all time high TTM EBITDA for PetMed Express?
  • What is PetMed Express TTM EBITDA year-on-year change?

What is PetMed Express annual EBITDA?

The current annual EBITDA of PETS is -$1.11 M

What is the all time high annual EBITDA for PetMed Express?

PetMed Express all-time high annual EBITDA is $54.26 M

What is PetMed Express annual EBITDA year-on-year change?

Over the past year, PETS annual EBITDA has changed by -$10.70 M (-111.52%)

What is PetMed Express quarterly EBITDA?

The current quarterly EBITDA of PETS is $2.21 M

What is the all time high quarterly EBITDA for PetMed Express?

PetMed Express all-time high quarterly EBITDA is $16.31 M

What is PetMed Express quarterly EBITDA year-on-year change?

Over the past year, PETS quarterly EBITDA has changed by +$940.00 K (+73.90%)

What is PetMed Express TTM EBITDA?

The current TTM EBITDA of PETS is $5.08 M

What is the all time high TTM EBITDA for PetMed Express?

PetMed Express all-time high TTM EBITDA is $56.61 M

What is PetMed Express TTM EBITDA year-on-year change?

Over the past year, PETS TTM EBITDA has changed by +$3.30 M (+185.75%)